Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SINOVAC BIOTECH LTD.

(SVA)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Sinovac Biotech : Says its New Research Shows Third Dose if its COVID-19 Vaccine More Effective Against COVID-19, Including Delta Variant

09/09/2021 | 08:25am EST


ę MT Newswires 2021
All news about SINOVAC BIOTECH LTD.
11/23Mexico eyes COVID-19 vaccine booster shots, especially for older adults
RE
11/20Hong Kong authorises Sinovac vaccine for children aged 3-17
RE
11/10Preliminary Results Show SINOVAC's COVID-19 Vaccine Demonstrates Good Safety Profile Am..
PU
11/09Preliminary Results Show SINOVAC's COVID-19 Vaccine Demonstrates Good Safety Profile Am..
BU
11/09Sinovac Biotech Ltd. Announces New Preliminary Data on its Inactivated COVID-19 Vaccine..
CI
11/08UK to add China's Sinovac, India's Covaxin to approved vaccine list
RE
11/03Indian home-grown COVID-19 shot wins WHO emergency use approval
RE
11/03Indian home-grown COVID-19 shot wins WHO emergency use approval
RE
11/03Hong Kong to launch COVID-19 booster campaign from next week
RE
10/30China's Xi calls for COVID-19 vaccine mutual recognition
RE
More news
Financials (USD)
Sales 2020 511 M - -
Net income 2020 110 M - -
Net cash 2020 1 040 M - -
P/E ratio 2020 6,66x
Yield 2020 -
Capitalization 642 M 642 M -
EV / Sales 2019 1,86x
EV / Sales 2020 -0,78x
Nbr of Employees 1 959
Free-Float 33,5%
Chart SINOVAC BIOTECH LTD.
Duration : Period :
Sinovac Biotech Ltd. Technical Analysis Chart | SVA | AGP8696W1045 | MarketScreener
Income Statement Evolution
Managers and Directors
Wei Dong Yin Chairman, President, CEO, Secretary & MD
Nan Wang CFO & Vice President-Business Development
Qiang Gao Chief Operating Officer & Vice President
Yuk Lam Lo Independent Director
Jian Li Independent Director
Sector and Competitors
1st jan.Capi. (M$)
SINOVAC BIOTECH LTD.0.00%642
CSL LIMITED7.81%100 628
WUXI BIOLOGICS (CAYMAN) INC.-0.29%58 683
SAMSUNG BIOLOGICS CO.,LTD.7.99%50 240
ALEXION PHARMACEUTICALS, INC.0.00%40 336
BIOGEN INC.-6.27%33 712